Anil Soni

Anil Soni Anil Soni has spent the last decade building and scaling two leading organizations in global health. He left McKinsey & Company in 2002 to serve as chief of staff to the first Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, developing its operational model, recruiting its talent and raising its first $5 billion. After founding the Fund’s “Friends of the Global Fight” satellite in Washington, Anil joined the William J. Clinton Foundation in 2005, where he led a string of deals with pharmaceutical companies to lower the prices of AIDS drugs. He expanded the scope of the Clinton Health Access Initiative (CHAI) with a $500M five-year deal with UNITAID to expand pediatric AIDS treatment; that program dropped drug and diagnostic prices by 90% and has treated 350,000 children to date. Anil was appointed CEO of CHAI in 2008. Under his tenure, he helped the organization manage its growth – to more than 500 staff and $200M in annual spending; establish itself as an independent nonprofit; and strengthen its donor and external relations. Anil decided to leave CHAI to move back into the private sector. During his transition, Anil served as senior advisor to the Bill & Melinda Gates Foundation and to the Business Leadership Council for a Generation Born HIV Free (BLC). In 2013, Anil joined Mylan, one of the world’s largest generic and specialty pharmaceutical manufacturers, where he serves as the global commercial leader for its work in HIV/AIDS and infectious disease.